Early sedative for sepsis shock patients
Treatments studied
Part of Infections clinical trials.
This trial tests an early use of a sedative medicine called dexmedetomidine in people with septic shock. It aims to calm the body's stress response, which might improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have septic shock, a severe infection-related condition
- You can start the treatment within 24 hours of diagnosis
- Your illness severity score (APACHE II) is above 10
- You are not pregnant or breastfeeding
- You do not have certain heart rhythm problems or a very slow heart rate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a sedative called dexmedetomidine affects blood flow in tiny vessels under the tongue and overall circulation in patients with septic shock. It may help doctors choose better sedation to improve recovery.
This trial tests if dexmedetomidine, a sedative, can help protect the kidneys of critically ill patients with sepsis who develop acute kidney injury (a sudden drop in kidney function). It is for adults in the ICU who need a breathing tube or mask within 48 hours of kidney injury.
This study tests a medicine called dexmedetomidine, which may help calm the body's stress response during septic shock, possibly improving blood pressure and organ function. The trial is for patients in intensive care who are already on strong blood pressure support but are not improving.
This study tests whether a drug called dexmedetomidine (a sedative) can help calm patients with severe brain injury who are on a breathing machine in the intensive care unit. If you or your loved one is in this situation, this treatment might reduce agitation and improve recovery.
This study tests an early sedation medicine called dexmedetomidine in patients 65 and older who need a breathing tube. It may help reduce confusion and time on the machine compared to usual care.
This trial tests whether a sedating medicine called dexmedetomidine can reduce the risk of “delirium” (sudden confusion) in the intensive care unit after open-heart surgery. If you’re having certain heart operations, it may help protect your thinking and alertness during recovery.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.